Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 01, 2018
Source ID
10.1016/j.ymgme.2018.02.009

Entities

People

  • Aaron Schindeler
  • David G. Little
  • Emily R. Vasiljevski
  • Kathy Mikulec
  • Lauren Peacock
  • Matthew A. Summers

Organizations

  • Children's Tumor Foundation
  • United States Department of Defense